Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source link
Biogen to Cut Roughly 11% of Workforce
The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link
At Startup That Says Its AI Writes Medical Records, Humans Do a Lot of the Work
DeepScribe relies on a team of people to review tech-generated reports, listen to medical conversations and revise the records. Source link
J&J Revenue Up on Surge in Heart Procedures
Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share. Source link
Tornado Damages Key Pfizer Drugmaking Plant
The plant in Rocky Mount, N.C., produces a quarter of the sterile injectable medicines used by U.S. hospitals. Source link
To Treat Extreme Heat, Ice-Packed Body Bags and Wet Gowns
Ice, water and fans are among the remedies for nausea, muscle cramps and comas caused by high body temperatures. Source link
FDA Approves First RSV Drug to Protect All Infants
While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. Source link
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link
Eli Lilly to Acquire Versanis Bio, Maker of Obesity Treatment
Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional payments if certain milestones are
UnitedHealth Lifts Earnings Outlook
Healthcare and insurance company UnitedHealth Group said its revenue grew 16% to $92.9 billion in the latest quarter. Source link